Cannabinoids in multiple sclerosis: urgent need for long term trials
J Neurol Neurosurg Psychiatry
.
2005 Dec;76(12):1612.
doi: 10.1136/jnnp.2005.075333.
Authors
J Killestein
1
,
B M J Uitdehaag
Affiliation
1
Department of Neurology, VU Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
[email protected]
PMID:
16291880
PMCID:
PMC1739426
DOI:
10.1136/jnnp.2005.075333
No abstract available
Publication types
Comment
Research Support, Non-U.S. Gov't
MeSH terms
Cannabinoids / therapeutic use*
Clinical Trials as Topic
Humans
Multiple Sclerosis / drug therapy*
Treatment Outcome
Substances
Cannabinoids